<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23158653</article-id>
      <article-id pub-id-type="pmc">3519516</article-id>
      <article-id pub-id-type="publisher-id">1756-0500-5-638</article-id>
      <article-id pub-id-type="doi">10.1186/1756-0500-5-638</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pulmonary lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult: a case report and review of the literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Moubax</surname>
            <given-names>Kim</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kimmoubax970@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Wuyts</surname>
            <given-names>Wim</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>wim.wuyts@uzleuven.be</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Vandecaveye</surname>
            <given-names>Vincent</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>vincent.vandecaveye@uzleuven.be</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A4">
          <name>
            <surname>Prenen</surname>
            <given-names>Hans</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>hans.prenen@uzleuven.be</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Gastroenterology, University Hospitals Leuven, Digestive Oncology Unit, Herestraat 49, 3000, Leuven, Belgium</aff>
      <aff id="I2"><label>2</label>Department of Pneumology, University Hospitals Leuven, Leuven, Belgium</aff>
      <aff id="I3"><label>3</label>Department of Radiology, University Hospitals Leuven, Leuven, Belgium</aff>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>11</month>
        <year>2012</year>
      </pub-date>
      <volume>5</volume>
      <fpage>638</fpage>
      <lpage>638</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>6</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>11</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2012 Moubax et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <copyright-holder>Moubax et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1756-0500/5/638"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Lymphangitic carcinomatosis as a manifestation of gastric carcinoma is rare. The presenting symptoms are misleading and nonspecific, often resulting in delayed diagnosis.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We present a case of a 24 year old male with progressive dyspnea. Initial radiologic assessment suggested interstitial lung disease, which was subsequently treated with antibiotics and corticosteroids. However, endoscopy and whole body diffusion-weighted magnetic resonance imaging revealed a metastatic gastric cancer with the presence of lymphangitic carcinomatosis.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Pulmonary lymphangitic carcinomatosis is a rare manifestation of metastatic gastric cancer. Patients present with severe but non-specific respiratory complaints. Definitive diagnosis can be achieved by transbronchial biopsy. Prognosis is poor and optimal treatment is not defined. Whole body diffusion-weighted magnetic resonance imaging is a promising imaging tool for the diagnosis of metastatic gastric cancer.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Lymphangitic carcinomatosis</kwd>
        <kwd>Gastric cancer</kwd>
        <kwd>Whole body MRI</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Pulmonary lymphangitic carcinomatosis is present in 6-8% of patients with lung metastases
[<xref ref-type="bibr" rid="B1">1</xref>]. Infiltration of the pleural, peribronchial and perivascular lymphatics by neoplastic cells was first noted in 1829. The histopathology was described in detail in 1874. The spread of tumour cells to the pulmonary lymphatic system or the adjacent interstitial tissue results in thickening of the bronchovascular bundles and septa. Desmoplastic reaction, due to proliferation of neoplastic cells and lymphatic dilatation by edema fluid or tumour secretions contribute to this interstitial thickening
[<xref ref-type="bibr" rid="B2">2</xref>]. Spread of the neoplasm outside the interstitium and lymphatic spaces into the adjacent parenchyma can result in a nodular pattern
[<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>Herein we report a very rare case of lymphangitic carcinomatosis as a primary manifestation of gastric carcinoma in a young adult.</p>
    </sec>
    <sec>
      <title>Case Presentation</title>
      <p>A 24 year old man presented at the emergency department after an episode of hemoptysis. For six months he complained about a dry cough. There was no respiratory-related pain but he had experienced shortness of breath during exercise for four weeks. He had not suffered from any fever or chills in the last six months. He reported occasional night sweats in the past three months.</p>
      <p>At the age of six he had suffered from tuberculosis but had made a complete recovery. He didn&#x2019;t smoke or use drugs or medication routinely. His family history was negative. The patient had no pets and had never been exposed to products that cause pulmonary damage.</p>
      <p>On physical examination the lungs were clear on auscultation and he had normal heart sounds. His blood pressure was 130/80, his heart rate was 83 beats per minute, his O<sub>2</sub> saturation was 95% and his respiratory frequency was fourteen times per minute.</p>
      <p>There was a slight decrease in arterial pO2 (90 mmHg) with a normal pCO2 (38 mmHg).</p>
      <p>Chest radiography showed a diffuse reticulonodular pattern (Figure
<xref ref-type="fig" rid="F1">1</xref>). An additional computed tomography (CT) showed areas of ground-opacification and diffusely thickened interlobular septa. There were also hilar and mediastinal lymphadenopathies (Figure
<xref ref-type="fig" rid="F2">2</xref>A).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Chest X-ray at time of first admission shows diffuse diffuse reticulonodular pattern.</p>
        </caption>
        <graphic xlink:href="1756-0500-5-638-1"/>
      </fig>
      <fig id="F2" position="float">
        <label>Figure 2</label>
        <caption>
          <p><bold>(A) High resolution computed tomography of the chest at time of first admission shows bilateral areas of ground-glass opacification and diffusely thickened interlobular septa.</bold> Moreover it showed the presence of hilar and mediastinal adenopathies. (<bold>B</bold>) Repeat scan after broad-spectrum antibiotics and high-dose corticosteroids shows progression of the interstitial disease.</p>
        </caption>
        <graphic xlink:href="1756-0500-5-638-2"/>
      </fig>
      <p>Radiological evaluation was most suggestive of interstitial lung disease with a broad differential diagnosis including: infections other than tuberculosis, hypersensitivity pneumonitis, vasculitis, sarcoidosis, non-specific interstitial pneumonia, pulmonary alveolar proteinosis and lymphangitic carcinomatosis.</p>
      <p>Biochemically there were no signs of inflammation (Table
<xref ref-type="table" rid="T1">1</xref>). An auto-immune disease was suspected so auto-antibodies were determined. Antinuclear Factor, Anti-Neutrophil Cytoplasmic Antibody, anti-Cyclic Citrullinated Protein antibodies and Rheumatoid Factor were all negative. The levels of immunoglobulins were normal and specific IgG for Aspergillus fumigatus, Alternaria alternata and Micropolyspora faeni were all negative.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Blood results at first admission and in our hospital</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
            <col align="center"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Test</bold>
              </th>
              <th align="center">
                <bold>First admission</bold>
              </th>
              <th align="center">
                <bold>Our hospital</bold>
              </th>
              <th align="center">
                <bold>Normal value</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">Hemoglobin (g/dl)<hr/></td>
              <td align="center" valign="bottom">15.3<hr/></td>
              <td align="center" valign="bottom">14.0<hr/></td>
              <td align="center" valign="bottom">14-18<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">White-cell count (x10^9/l)<hr/></td>
              <td align="center" valign="bottom">8.9<hr/></td>
              <td align="center" valign="bottom">17.3<hr/></td>
              <td align="center" valign="bottom">4-10<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Neutrophils (%)<hr/></td>
              <td align="center" valign="bottom">69.6<hr/></td>
              <td align="center" valign="bottom">79<hr/></td>
              <td align="center" valign="bottom">38-77<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Lymphocytes (%)<hr/></td>
              <td align="center" valign="bottom">22.7<hr/></td>
              <td align="center" valign="bottom">11.3<hr/></td>
              <td align="center" valign="bottom">20-50<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Platelet count (x10^9/l)<hr/></td>
              <td align="center" valign="bottom">330<hr/></td>
              <td align="center" valign="bottom">371<hr/></td>
              <td align="center" valign="bottom">150-450<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Creatinin (mg/dl)<hr/></td>
              <td align="center" valign="bottom">0.75<hr/></td>
              <td align="center" valign="bottom">0.73<hr/></td>
              <td align="center" valign="bottom">0.7-1.3<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Ureum (mg/dl)<hr/></td>
              <td align="center" valign="bottom">37<hr/></td>
              <td align="center" valign="bottom">35<hr/></td>
              <td align="center" valign="bottom">&lt;50<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">C-reactive protein (mg/l)<hr/></td>
              <td align="center" valign="bottom">3.8<hr/></td>
              <td align="center" valign="bottom">10.5<hr/></td>
              <td align="center" valign="bottom">&lt; 5<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Prothrombin time (ratio)<hr/></td>
              <td align="center" valign="bottom">1.05<hr/></td>
              <td align="center" valign="bottom">1.1<hr/></td>
              <td align="center" valign="bottom">0.9-1.2<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Aspartate aminotransferase (U/l)<hr/></td>
              <td align="center" valign="bottom">35<hr/></td>
              <td align="center" valign="bottom">20<hr/></td>
              <td align="center" valign="bottom">&lt; 38<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Alanine aminotransferase (U/l)<hr/></td>
              <td align="center" valign="bottom">43<hr/></td>
              <td align="center" valign="bottom">35<hr/></td>
              <td align="center" valign="bottom">&lt; 41<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Gamma-GT (U/l)<hr/></td>
              <td align="center" valign="bottom">41<hr/></td>
              <td align="center" valign="bottom">27<hr/></td>
              <td align="center" valign="bottom">&lt; 53<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Alkaline phosphate (U/l)<hr/></td>
              <td align="center" valign="bottom">253<hr/></td>
              <td align="center" valign="bottom">287<hr/></td>
              <td align="center" valign="bottom">&lt; 270<hr/></td>
            </tr>
            <tr>
              <td align="left">Lactate dehydrogenase (U/l)</td>
              <td align="center">356</td>
              <td align="center">302</td>
              <td align="center">240-480</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Echocardiography showed normal function of the left ventricle with no signs of pulmonary hypertension. There was minimal pericardial effusion and no hemodynamic repercussion.</p>
      <p>Broad-spectrum antibiotics were given for 14 days in case of eventual (atypical) infection. His clinical situation did not improve so a bronchoscopy was performed with bronchoalveolar lavage. This showed bilateral inflamed mucosa. A PCR was negative for Mycoplasma and Chlamydia. The cultures and the Ziehl-Nielsen staining were negative. PCR of the urine was negative for Legionella. Treatment was subsequently altered to high dose corticosteroids because of the suspicion of an interstitial lung disease.</p>
      <p>As the patient developed progressive shortness of breath and became oxygen dependent, even under therapy with corticosteroids, the patient was referred to our university hospital for a second opinion. He had lost six pounds since the start of his complaints. Examination of the patient&#x2019;s abdomen and heart sounds were unremarkable. We heard ronchi in the base of both lungs. There were clinically no enlarged lymph nodes, skin changes or peripheral edema.</p>
      <p>Biochemically there was leucocytosis (17,3 x10<sup>-9</sup>/L compared to the normal limit: 4,3-10,0 x10<sup>-9</sup>/L) and C-reactive protein levels of 10,5 mg/L (normal &lt;5 mg/L) (Table
<xref ref-type="table" rid="T1">1</xref>).</p>
      <p>The arterial pO2 was decreased to 76 mmHg with a pCO2 of 37,5 mmHg and a pH of 7,45. The ground-glass opacities and thickening of interlobular septa at repeat CT-scan (Figure
<xref ref-type="fig" rid="F2">2</xref>B) were clearly increased compared with the scan six weeks earlier. A spirometry showed a mixed obstructive restrictive pattern. Central biopsies were taken with bronchoscopy. Anatomopathological examination revealed the presence of metastatic carcinoma, probably stomach, pancreas or bile duct in origin.</p>
      <p>An additional gastroscopy was performed. This showed an image of an extended complicated ulceration of the antrum, suspicious for malignancy. Anatomopathological evaluation of the biopsies of the ulceration at gastroscopy showed a primary adenocarcinoma of the stomach, with focal signet ring differentiation.</p>
      <p>A whole body diffusion-weighted Magnetic Resonance Imaging (MRI) examination (WB-DWI) confirmed the presence of a large tumour at the lesser curvature of the stomach (Figure
<xref ref-type="fig" rid="F3">3</xref>A, B; arrow) with diffuse lung, pleural and mediastinal metastases as well as skeletal metastases in a right-sided rib and right iliac wing, depicted as clearly hyperintense lesions on DWI-images (Figure
<xref ref-type="fig" rid="F3">3</xref>C, D) . Biochemically the patient had a Carcino-embryonal antigen of 7,3 mg/L (normally &lt;3,8 mg/L).</p>
      <fig id="F3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>(A,B) WB-DWI with b1000-images and T2-weighted images in the coronal plane shows a tumoral mass in the lesser curvature of the stomach (arrow), (C,D) with diffuse metastases in the lungs and mediastinum as well as skeletal metastases in a right-sided rib and right iliac wing (arrows).</p>
        </caption>
        <graphic xlink:href="1756-0500-5-638-3"/>
      </fig>
      <p>After establishing this final diagnosis, biweekly chemotherapy was started with cisplatinum plus 5-Fluoro-Uracil; this was well tolerated by the patient. Immediately after the start of the chemotherapy the patients&#x2019; dyspnea improved and he did not need oxygen administration.</p>
      <p>A radiologic evaluation after 2 months of treatment revealed partial remission according to RECIST criteria, with resolution of clinical symptoms. There was clear, be it partial, regression of the primary tumour, lung, pleural, mediastinal and skeletal metastases, depicted by a clear loss of hyperintensity on DWI-images (Figure
<xref ref-type="fig" rid="F4">4</xref>, arrows indicate site of gastric cancer and skeletal metastases).</p>
      <fig id="F4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>(A,B) WB-DWI with b1000-images and T2-weighted images in the coronal plane shows clear partial regression of the gastric tumour (arrow), (C,D) diffuse metastases in the lungs and mediastinum and skeletal metastases in a right-sided rib and right iliac wing (arrows).</p>
        </caption>
        <graphic xlink:href="1756-0500-5-638-4"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>The most common primary tumours associated with pulmonary lymphangitic carcinomatosis are breast, stomach, pancreas, lung, and prostate cancer (Table
<xref ref-type="table" rid="T2">2</xref>)
[<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>common locations of primary tumours associated with pulmonary lymphangitic carcinomatosis (1)</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="center"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">
                <bold>Location</bold>
              </th>
              <th align="center">
                <bold>% of all cases</bold>
              </th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">
                <bold>Breast cancer</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">33<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Gastric cancer</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">29<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Pancreatic cancer</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">17<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Lung cancer</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">4<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Prostate cancer</bold>
                <hr/>
              </td>
              <td align="center" valign="bottom">3<hr/></td>
            </tr>
            <tr>
              <td align="left">
                <bold>Other cancers</bold>
              </td>
              <td align="center">14</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>This has been confirmed in a retrospective study with 43 patients with lymphangitic carcinomatosis: 23 patients had primary lung cancer, 9 breast cancer, 8 with large intestinal carcinoma and 6 gastric carcinoma
[<xref ref-type="bibr" rid="B3">3</xref>]. However, virtually any metastatic neoplasm can cause pulmonary lymphangitic carcinomatosis, for example there are case reports where the primary tumours were of cutaneous angiosarcoma or lip cancer
[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. In patients with gastric cancer the lymphatic spread is most commonly directed through the diaphragm and pleural surfaces, or directed in a retrograde way through the lymphatics from hilar lymph node metastases
[<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>Gastric cancer is one of the most common cancers worldwide, accounting for about eight percent of new cancers
[<xref ref-type="bibr" rid="B7">7</xref>]. Although the worldwide incidence has declined rapidly over the recent few decades, the absolute number of new cases per year is increasing again, mainly due to aging of the world&#x2019;s population. Furthermore, for reasons that are unclear, the trend towards declining incidence in young patients has been interrupted and replaced by an upward trend in recent years
[<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>There are two distinct pathological types of gastric adenocarcinoma: intestinal (well-differentiated) and diffuse (undifferentiated), each with distinct morphologic appearances, pathogenesis, and genetic profiles
[<xref ref-type="bibr" rid="B9">9</xref>]. The morphological differences are attributable to intercellular adhesion molecules, which are well preserved in intestinal-type tumours and defective in diffuse carcinomas
[<xref ref-type="bibr" rid="B10">10</xref>]. The main carcinogenic event in diffuse adenocarcinoma of the stomach is loss of expression of E-cadherin, a key cell surface protein for establishing intercellular connections. Clinically, diffuse adenocarcinomas can give rise to infiltration of the gastric wall (i.e., linitis plastica). Diffuse type cancers are highly metastatic and characterized by rapid disease progression and a poor prognosis
[<xref ref-type="bibr" rid="B11">11</xref>]. Signet ring histology is an independent predictor of poor prognosis in gastric adenocarcinoma
[<xref ref-type="bibr" rid="B12">12</xref>]. The prognosis of an adenocarcinoma of the stomach is highly dependent on the stage in which the tumour is detected
[<xref ref-type="bibr" rid="B13">13</xref>]. Accurate staging is pivotal prior in selecting appropriate therapy. MRI is emerging as an efficient whole-body imaging modality combining anatomical and functional sequences in clinically efficient scanning times with adequate spatial resolution. Several studies have indicated the additional value of WB-DWI to anatomical imaging for tumour detection, staging and (early) treatment assessment in various solid tumours
[<xref ref-type="bibr" rid="B14">14</xref>]. WB-DWI depicts tumoral lesions by measuring water diffusion differences, which correlate with cellular density. Tumours are depicted with high signal compared to the background tissue. The resulting high contrast resolution allows for better detection of primary tumours of the gastro-intestinal tract and metastases compared to CT. In particular gastric tumours, liver metastases, lymph adenopathies, peritoneal and skeletal metastases can be detected with high accuracy
[<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>].</p>
      <p>Based on these properties and the known variable accuracy of fluorodeoxyglucose (FDG) positron emission tomography in staging gastric cancer, we opted for WB-DWI for staging and follow-up in this specific setting. Additionally, WB-DWI obviates the need for contrast-agent injection, making it useful in patients with impaired renal function or known contrast-allergy.</p>
      <p>Patients with primary gastric cancer and lymphangitic carcinomatosis usually present with progressive shortness of breath lasting for two to four months before definite diagnosis
[<xref ref-type="bibr" rid="B6">6</xref>]. Often these patients experience no gastric complaints at all. In a series of six young patients (aged from 21&#x2013;29 years) only one had gastrointestinal symptoms (nausea and epigastric burning)
[<xref ref-type="bibr" rid="B18">18</xref>]. A study of pulmonary function in patients with lymphangitic carcinomatosis showed a restrictive ventilatory function defect, a reduction in the diffusing capacity, reduced compliance and hypoxemia without hypercapnia
[<xref ref-type="bibr" rid="B19">19</xref>]. Our patient had an obstructive and restrictive lung pattern, but his lung function was not well performed because of the pain.</p>
      <p>Chest radiography and CT of gastric patients have various and often nonspecific appearances or may be normal (Table
<xref ref-type="table" rid="T3">3</xref>)
[<xref ref-type="bibr" rid="B6">6</xref>]. Due to lack of specific radiological features, the final diagnosis can often only be made by biopsy. In the study of Dennstedt et al. the final diagnosis was only made at autopsy in four of six patients with a primary gastric tumour and lymphangitic carcinomatosis
[<xref ref-type="bibr" rid="B18">18</xref>]. In general, diagnosis may be delayed due to the combination of aspecific symptoms, uncertain initial diagnostic work-up and a low index of suspicion for malignancy.</p>
      <table-wrap position="float" id="T3">
        <label>Table 3</label>
        <caption>
          <p>Radiologic characteristics of pulmonary lymphangitic carcinomatosis (6)</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col/>
          </colgroup>
          <thead>
            <tr>
              <th align="left">&#xA0;</th>
              <td>&#xA0;</td>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">
                <bold>Chest radiography</bold>
                <hr/>
              </td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Coarse bronchovascular markings with irregular outline<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Coarse reticulonodular pattern with intraparenchymal extension of tumour<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Unilateral or bilateral changes predominantly in the lower lobes of the lungs<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Kerley A and B lines<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Hilar and mediastinal lymphadenopathy (20-40% of cases); usually asymmetric<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Pleural effusion (30-50% of cases)<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;No abnormalities (30-50% of cases)<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">
                <bold>Chest CT scan</bold>
                <hr/>
              </td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Smooth (early stage) and nodular (late stage) thickening of interlobular septa and peribronchovascular interstitium<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Polygonal arcades with thickened limbs from thickened septa of adjacent lobules<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left" valign="bottom">-&#x2003;Normal lung architecture is maintained<hr/></td>
              <td>&#xA0;</td>
            </tr>
            <tr>
              <td align="left">-&#x2003;Ground-glass appearance from interstitial edema or extension of the tumour into the parenchyma</td>
              <td>&#xA0;</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The general prognosis of patients with lymphangitis carcinomatosis is poor with an average survival of only three months in historical series
[<xref ref-type="bibr" rid="B1">1</xref>]. Patients included in the study of Dennstedt et al. (six patients with an average age of 26 years and a primary gastric tumour) had a mean survival time of only 22 days after their first admission to hospital
[<xref ref-type="bibr" rid="B14">14</xref>]. Anatomopathological examination revealed an adenocarcinoma of the diffuse type in all of the patients
[<xref ref-type="bibr" rid="B18">18</xref>]. Moreover, both the patient in the study of Desigan
[<xref ref-type="bibr" rid="B6">6</xref>] and our patient had an adenocarcinoma with focal signet cell carcinoma, which is associated with a worse prognosis
[<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B20">20</xref>], although there are publications that didn&#x2019;t show a prognostic effect
[<xref ref-type="bibr" rid="B21">21</xref>].</p>
      <p>We might therefore conclude that an adenocarcinoma of the diffuse type might be a predictor for lymphangitic carcinomatosis. The number of patients is too small to make definitive conclusions.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusion</title>
      <p>It is important to consider the possibility of lymphangitic carcinomatosis in patients with: progressive dyspnoea; no other known causes of interstitial lung disease; or an interstitial pattern demonstrated on CT or chest radiographs. When there is doubt about the exact diagnosis, a biopsy must be performed in order not to lose time for starting the necessary treatment, even in young patients where a malignancy is not expected.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent for publication of the clinical details and clinical images was obtained from the patient.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>HP and KM designed the study. HP, WW, KM and VV drafted and edited the manuscript. HP, KM and WW treated and observed the patient including follow-up. VV acquired the radiographic pictures. All authors read and approved the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>We would like to thank Claire Palles for the linguistic revision of the manuscript.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bruce</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Heys</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Eremin</surname>
            <given-names>O</given-names>
          </name>
          <article-title>Lymphangitis carcinomatosa: a literature review</article-title>
          <source>J R Coll Surg Edinb</source>
          <year>1996</year>
          <volume>41</volume>
          <fpage>7</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">8930034</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Thomas</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lenox</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Pulmonary lymphangitic carcinomatosis as a primary manifestation of colon cancer in a young adult</article-title>
          <source>CMAJ</source>
          <year>2008</year>
          <volume>179</volume>
          <fpage>338</fpage>
          <lpage>340</lpage>
          <pub-id pub-id-type="doi">10.1503/cmaj.080142</pub-id>
          <pub-id pub-id-type="pmid">18695182</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <article-title>Clinical features and diagnosis of pulmonary lymphangitic carcinomatosis</article-title>
          <source>Ai Zheng</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>1127</fpage>
          <lpage>1130</lpage>
          <pub-id pub-id-type="pmid">16965655</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chi-Ting</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Shih-Ming</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kun-Eng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hsin-Nung</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Pulmonary lumphangitic sarcomatosis from cutaneous angiosarcoma: an unusual presentation of diffuse interstitial lung disease</article-title>
          <source>Jpn J Clin Oncol</source>
          <year>2000</year>
          <volume>30</volume>
          <fpage>37</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1093/jjco/hyd005</pub-id>
          <pub-id pub-id-type="pmid">10770568</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Babu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Salih</surname>
            <given-names>S</given-names>
          </name>
          <article-title>A rare presentation of pulmonary lymphangitic carcinomatosis in cancer of lip: case report</article-title>
          <source>World J Surg Oncol</source>
          <year>2011</year>
          <volume>9</volume>
          <fpage>77</fpage>
          <pub-id pub-id-type="doi">10.1186/1477-7819-9-77</pub-id>
          <pub-id pub-id-type="pmid">21756338</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Desigan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wofford</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Dunn</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Vaughan</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Occult gastric cancer manifested by progressive shortness of breath in a young adult</article-title>
          <source>Southern med j</source>
          <year>1986</year>
          <volume>79</volume>
          <fpage>1173</fpage>
          <lpage>1176</lpage>
          <pub-id pub-id-type="doi">10.1097/00007611-198609000-00037</pub-id>
          <pub-id pub-id-type="pmid">3018944</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bray</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Center</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Ferlay</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ward</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Forman</surname>
            <given-names>D</given-names>
          </name>
          <article-title>Global cancer statistics</article-title>
          <source>CA Cancer J Clin</source>
          <year>2011</year>
          <volume>61</volume>
          <fpage>69</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="doi">10.3322/caac.20107</pub-id>
          <pub-id pub-id-type="pmid">21296855</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Correa</surname>
            <given-names>P</given-names>
          </name>
          <article-title>Gastric cancer: two epidemics?</article-title>
          <source>Dig Dis Sci</source>
          <year>2011</year>
          <volume>56</volume>
          <fpage>1585</fpage>
          <lpage>1586</lpage>
          <pub-id pub-id-type="doi">10.1007/s10620-011-1642-x</pub-id>
          <pub-id pub-id-type="pmid">21394461</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lauren</surname>
            <given-names>P</given-names>
          </name>
          <article-title>The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification</article-title>
          <source>Acta pathol microb scand</source>
          <year>1965</year>
          <volume>64</volume>
          <fpage>31</fpage>
          <lpage>49</lpage>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shah</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Khanin</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Janjigian</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Klimstra</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Gerdes</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kelsen</surname>
            <given-names>DP</given-names>
          </name>
          <article-title>Molecular classification of gastric cancer: a new paradigm</article-title>
          <source>Clin Cancer Res</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>2693</fpage>
          <lpage>2701</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-2203</pub-id>
          <pub-id pub-id-type="pmid">21430069</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yashiro</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Nishimura</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Sowa</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis</article-title>
          <source>Br J Cancer</source>
          <year>1995</year>
          <volume>72</volume>
          <fpage>1200</fpage>
          <lpage>1210</lpage>
          <pub-id pub-id-type="doi">10.1038/bjc.1995.486</pub-id>
          <pub-id pub-id-type="pmid">7577468</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Piessen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Messager</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Leteurtre</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Jean-Pierre</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mariette</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation</article-title>
          <source>Ann Surg</source>
          <year>2009</year>
          <volume>250</volume>
          <fpage>878</fpage>
          <lpage>887</lpage>
          <pub-id pub-id-type="doi">10.1097/SLA.0b013e3181b21c7b</pub-id>
          <pub-id pub-id-type="pmid">19855261</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hyatt</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Pauli</surname>
            <given-names>PE</given-names>
          </name>
          <name>
            <surname>Wassei</surname>
            <given-names>W</given-names>
          </name>
          <article-title>Gastric oncology: an update</article-title>
          <source>Curr Opin Gastroenterol</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>570</fpage>
          <lpage>578</lpage>
          <pub-id pub-id-type="doi">10.1097/MOG.0b013e328331b5c9</pub-id>
          <pub-id pub-id-type="pmid">19816172</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kwee</surname>
            <given-names>TC</given-names>
          </name>
          <name>
            <surname>Takahara</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ochiai</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Katahira</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Van Cauteren</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Imai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nievelstein</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Luijten</surname>
            <given-names>PR</given-names>
          </name>
          <article-title>Whole-body diffusion-weighted magnetic resonance imaging</article-title>
          <source>Eur J Radiol</source>
          <year>2009</year>
          <volume>70</volume>
          <fpage>409</fpage>
          <lpage>417</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejrad.2009.03.054</pub-id>
          <pub-id pub-id-type="pmid">19403255</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zhang</surname>
            <given-names>XP</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>ZY</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XT</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>YQ</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Q</given-names>
          </name>
          <article-title>Sandwich sign of Borrman type 4 gastric cancer on diffusion-weighted magnetic resonance imaging</article-title>
          <source>Eur J Radiol</source>
          <year>2012</year>
          <volume>81</volume>
          <fpage>2481</fpage>
          <lpage>2486</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejrad.2011.10.021</pub-id>
          <pub-id pub-id-type="pmid">22099950</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Low</surname>
            <given-names>RN</given-names>
          </name>
          <name>
            <surname>Barone</surname>
            <given-names>RM</given-names>
          </name>
          <article-title>Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures</article-title>
          <source>Ann Surg Oncol</source>
          <year>2012</year>
          <volume>19</volume>
          <fpage>1394</fpage>
          <lpage>1401</lpage>
          <pub-id pub-id-type="doi">10.1245/s10434-012-2236-3</pub-id>
          <pub-id pub-id-type="pmid">22302265</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Low</surname>
            <given-names>RN</given-names>
          </name>
          <article-title>Diffusion-weighted MR, imaging for whole body metastatic disease and lymphadenopathy</article-title>
          <source>Magn Reson Imag Clin N Am</source>
          <year>2009</year>
          <volume>17</volume>
          <fpage>245</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mric.2009.01.006</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Dennstedt</surname>
            <given-names>FE</given-names>
          </name>
          <name>
            <surname>Greenberg</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>HS</given-names>
          </name>
          <article-title>Pulmonary lymphangitic carcinomatosis from occult stomach carcinoma in young adults: an unusual cause of dyspnea</article-title>
          <source>Chest</source>
          <year>1983</year>
          <volume>84</volume>
          <fpage>787</fpage>
          <lpage>788</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.84.6.787</pub-id>
          <pub-id pub-id-type="pmid">6641323</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Emirgil</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zsoldos</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Heinemann</surname>
            <given-names>HO</given-names>
          </name>
          <article-title>Effect of metastatic carcinoma to the lung on pulmonary function in man</article-title>
          <source>Am J Med</source>
          <year>1964</year>
          <volume>36</volume>
          <fpage>382</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1016/0002-9343(64)90165-2</pub-id>
          <pub-id pub-id-type="pmid">14131883</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Li</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Hyung</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>WH</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>SH</given-names>
          </name>
          <article-title>Advanced gastric carcinoma with signet cell histology</article-title>
          <source>Oncology</source>
          <year>2007</year>
          <volume>72</volume>
          <fpage>34</fpage>
          <lpage>38</lpage>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Taghavi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jayajaran</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Davey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Willis</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Prognostic significance of signet ring gastric cancer</article-title>
          <source>Am Soc Clin Oncol</source>
          <year>2012</year>
          <volume>30</volume>
          <issue>28</issue>
          <fpage>3493</fpage>
          <lpage>3498</lpage>
          <pub-id pub-id-type="doi">10.1200/JCO.2012.42.6635</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
